- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06444945
Effects of Mulligan Mobilization With Movement as Compared to Kaltenborn Joint Mobilization in the Management of Knee Osteoarthritis
June 5, 2024 updated by: Foundation University Islamabad
This study is a randomised controlled trial and the purpose of this study is to determine the Effects of Mulligan mobilization with movement as compared to Kaltenborn joint mobilization in the management of knee osteoarthritis."
To determine the effects of Mulligan MWM as compared to Kaltenborn joint mobilization in terms of pain, function, range of motion and gait in persons with knee osteoarthritis.
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Islamabad, Pakistan
- Foundation University Islamabad
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Individuals aged 40-70 years (Osama et al, 2022)
- Having KOA history of no less than 3 months
- Knee pain less than 8/10 on numeric pain rating scale (NPRS).
- Radiological evidence of grade III or less on Kellgren classification
- Patients referred from rehab department
Exclusion Criteria:
- Those with signs of serious pathology, such as malignancy, inflammatory disorder or infection.
- History of trauma or fractures in lower extremity.
- Signs of lumbar radiculopathy or myelopathy.
- History of knee surgery or replacement.
- Receiving intra-articular steroid therapy in the preceding two months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mulligan MWM group
Group A receiving Mulligan MWM joint mobilization
|
Heating pad will be used for heating purpose.
TENS is used for symptomatic pain relief
It provides short term pain relief and to restore pain-free, functional movements by achieving full range at the joint
Resistance training increases muscle strength by making your muscles work against a weight or force.
|
|
Experimental: Kaltenborn mobilization group
Group B receiving Kaltenborn Joint mobilization
|
Heating pad will be used for heating purpose.
TENS is used for symptomatic pain relief
Resistance training increases muscle strength by making your muscles work against a weight or force.
The purpose of joint mobilization is to restore normal, painless joint function.
In restricted joints, this involves the restoration of joint play to normalize the roll-gliding that is essential to active movement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
knee pain
Time Frame: 2 weeks
|
knee pain will be measured using visual analogue scale (VAS) from 0-100mm.A higher score on VAS indicated greater pain.
|
2 weeks
|
|
Functional disability
Time Frame: 2 weeks
|
knee functional disability will be assessed using Knee Osteoarthritis and Outcome Score(KOOS) with a score ranging from 0-100.
A lower score on KOOS signifies greater functional disability
|
2 weeks
|
|
Knee range of motion
Time Frame: 2 weeks
|
knee range of motion will be measured using a goniometer.
A higher ROM signifies positive outcome.
|
2 weeks
|
|
Stride length
Time Frame: 2 weeks
|
Gait analysis will be done to analyze stride length.
A greater stride length signifies positive outcome and prognosis.
|
2 weeks
|
|
Gait velocity
Time Frame: 2 weeks
|
Gait analysis will be done to analyze gait velocity.
A greater gait velocity signifies positive outcome and prognosis.
|
2 weeks
|
|
Isometeric Muscle Strength
Time Frame: 2 weeks
|
Isometeric Muscle Strength will be quantified using dynamometer.
A higher score on dynamometer signifies greater muscle strength and good prognosis.
|
2 weeks
|
|
Walking related performance fatigability
Time Frame: 2 weeks
|
walking related performance fatigability will be measured using 6 minute walk test.
Greater fatigibility indicates poorer outcome.
|
2 weeks
|
|
Functional Capacity
Time Frame: 2 weeks
|
5 repetition sit to stand test will be used to determine knee related functional capacity which will be quantified in terms of time.
A smaller time will denote greater functional capacity.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Shanza Fatima, DPT, Foundation University Islamabad
- Principal Investigator: Muhammad Osama, PhD*, Foundation University Islamabad
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 10, 2024
Primary Completion (Estimated)
December 10, 2024
Study Completion (Estimated)
December 30, 2024
Study Registration Dates
First Submitted
May 27, 2024
First Submitted That Met QC Criteria
June 5, 2024
First Posted (Actual)
June 6, 2024
Study Record Updates
Last Update Posted (Actual)
June 6, 2024
Last Update Submitted That Met QC Criteria
June 5, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUI/CTR/2024/13
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Heating pad
-
The University of Texas Health Science Center at...WithdrawnPain | Anxiety | Distress, EmotionalUnited States
-
University of RedlandsActive, not recruitingHealthy ParticipantsUnited States
-
Vanderbilt UniversityCompletedHypertension | Multiple System Atrophy | Pure Autonomic Failure | Autonomic FailureUnited States
-
University of ZurichUniversity Hospital, ZürichRecruitingHealthy ParticipantsSwitzerland
-
Chang Gung Memorial HospitalCompletedHemodialysis-Induced Symptom | Intra-dialytic HypotensionTaiwan
-
Vanderbilt University Medical CenterRecruitingHypertension | Multiple System Atrophy | Pure Autonomic Failure | Autonomic FailureUnited States
-
Foundation University IslamabadEnrolling by invitationKnee OsteoarthritisPakistan
-
San Diego State UniversityCompletedGlucose Tolerance | HRVUnited States
-
Istanbul Saglik Bilimleri UniversityNot yet recruitingKnee Prosthesis
-
Lithuanian Sports UniversityCompleted